Cargando…
Correction to: Reconsidering tolerability of cancer treatments: opportunities to focus on the patient
Autores principales: | Peipert, John Devin, Smith, Mary Lou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385752/ https://www.ncbi.nlm.nih.gov/pubmed/35821450 http://dx.doi.org/10.1007/s00520-022-07276-z |
Ejemplares similares
-
Reconsidering tolerability of cancer treatments: opportunities to focus on the patient
por: Peipert, John Devin, et al.
Publicado: (2022) -
Correction to: How do patients interpret and respond to a single‑item global indicator of cancer treatment tolerability?
por: Peipert, John Devin, et al.
Publicado: (2023) -
Correction: Oral antiviral treatments for COVID-19: opportunities and challenges
por: Rahmah, Laila, et al.
Publicado: (2022) -
Correction: A systematic review and an individual patient data meta-analysis of ivermectin use in children weighing less than fifteen kilograms: Is it time to reconsider the current contraindication?
por: Jittamala, Podjanee, et al.
Publicado: (2023) -
Correction to: Early Treatment of COVID-19 Disease: A Missed Opportunity
por: Forrest, Jamie I., et al.
Publicado: (2020)